{
  "mapping_analysis": {
    "thesis_segments_analyzed": [
      "seg_3_001.md (Lines 1-350): Introduction & Research Questions",
      "seg_3_002.md (Lines 351-700): Technical Implementation & Monitoring", 
      "seg_3_003_improved.md (Lines 701-end): Validation Protocol & Compliance"
    ],
    "technical_report_key_findings": {
      "multi_agent_orchestration": {
        "llama_index_workflows": "Event-driven architecture with 5 specialized agents",
        "performance": "91% cost reduction with DeepSeek V3",
        "observability": "131 spans captured via Phoenix monitoring"
      },
      "deepseek_v3_implementation": {
        "model_specs": "671B parameters with MoE architecture",
        "cost_advantage": "$1.35 vs $15 per 1M tokens (91% reduction)",
        "performance": "30 test cases generated (120% of 25 target)"
      },
      "compliance_achievements": {
        "gamp_5": "100% compliance with NO FALLBACKS policy",
        "alcoa_plus": "All 9 principles satisfied with validation",
        "cfr_part_11": "Complete audit trail with electronic signatures"
      }
    }
  },
  "segment_assignments": {
    "seg_3_001": {
      "segment_focus": "Introduction, methodology foundation, research questions",
      "current_themes": [
        "Pharmaceutical CSV challenges",
        "Research methodology justification", 
        "LLM limitations in pharma context",
        "Multi-agent architectural decisions"
      ],
      "technical_content_assignments": [
        {
          "content": "Multi-agent LlamaIndex orchestration specifics",
          "insertion_priority": "HIGH",
          "rationale": "Directly supports RQ1 multi-agent optimization discussion",
          "specific_evidence": "5 specialized agents with event-driven architecture"
        },
        {
          "content": "DeepSeek V3 model selection rationale",
          "insertion_priority": "MEDIUM", 
          "rationale": "Supports cost/performance methodology decisions",
          "specific_evidence": "91% cost reduction justification"
        }
      ]
    },
    "seg_3_002": {
      "segment_focus": "Technical implementation details, monitoring, optimization",
      "current_themes": [
        "Phoenix observability integration",
        "Model optimization strategies",
        "Performance validation",
        "Real-time monitoring"
      ],
      "technical_content_assignments": [
        {
          "content": "Phoenix observability implementation details",
          "insertion_priority": "CRITICAL",
          "rationale": "Segment already discusses Phoenix - needs concrete implementation proof",
          "specific_evidence": "131 spans captured, custom span exporter, audit trail integration"
        },
        {
          "content": "ChromaDB integration for regulatory context",
          "insertion_priority": "HIGH",
          "rationale": "Supports regulatory knowledge retrieval discussion",
          "specific_evidence": "26 pharmaceutical documents indexed for GAMP-5 context"
        },
        {
          "content": "DeepSeek V3 production deployment specifics",
          "insertion_priority": "HIGH",
          "rationale": "Validates model optimization strategy claims",
          "specific_evidence": "30,000 max tokens, 0.1 temperature for deterministic compliance"
        }
      ]
    },
    "seg_3_003_improved": {
      "segment_focus": "Validation protocol, compliance framework, limitations",
      "current_themes": [
        "Implementation validation protocol",
        "ALCOA+ principles",
        "Regulatory compliance matrix",
        "Limitations acknowledgment"
      ],
      "technical_content_assignments": [
        {
          "content": "Concrete validation results and performance metrics",
          "insertion_priority": "CRITICAL",
          "rationale": "Segment discusses validation but lacks empirical evidence",
          "specific_evidence": "100% ALCOA+ compliance, 95%+ traceability achieved, 0% false positives"
        },
        {
          "content": "GAMP-5 categorization implementation",
          "insertion_priority": "HIGH",
          "rationale": "Supports regulatory compliance discussion with proof",
          "specific_evidence": "NO FALLBACKS policy, Category 5 system validation"
        },
        {
          "content": "OWASP LLM Top 10 security implementation",
          "insertion_priority": "HIGH",
          "rationale": "Addresses security limitations with concrete mitigations",
          "specific_evidence": "100% security mitigation effectiveness, zero vulnerabilities"
        }
      ]
    }
  },
  "content_distribution_strategy": {
    "principle": "MINIMAL_DISRUPTION",
    "approach": "Strategic enhancement rather than rewriting",
    "evidence_integration": "Concrete implementation details to support existing theoretical claims",
    "validation_priority": "Maintain existing validated text while adding empirical proof points"
  }
}